Lifestyle coaching for preventing Alzheimer's in APOE4 carriers
Part of Brain & nervous system, Mental health clinical trials.
This study tests a digital lifestyle coaching program designed to help prevent Alzheimer's disease in people who carry the APOE4 genetic variant, which increases risk. Over one year, you'll get personalized health coaching through apps and possibly a smart ring to track your progress.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a current 23andMe Research participant and have the APOE4 genetic variant.
- You are between 60 and 80 years old.
- You live in the United States and have an Android or iPhone smartphone that can download apps.
- You are willing to do a saliva test at the start and a finger-prick blood test three times during the study.
- You are not taking or planning to take GLP-1 medications (like Ozempic, Trulicity, or Victoza) in the next year.
- You have not been diagnosed with mild cognitive impairment, Alzheimer's, or other neurodegenerative diseases, and you have not used an Oura Ring recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study identifies people at high risk for Alzheimer's disease before symptoms develop, using genetics and digital tools to track brain health over time. If you qualify, you'll help researchers understand who will develop cognitive decline and potentially enable earlier interventions.
This study tests a personalized lifestyle program to help keep your memory sharp if you're at higher risk of thinking and memory problems. It involves coaching in areas like diet, exercise, and relaxation to see if it can slow or prevent age-related memory decline.
This study tests whether a special diet and supplements can improve body, brain, and longevity in people who carry the APOE e4 gene. It may help slow aging and support memory, but it requires a fairly restrictive health profile.
This study tests whether actively lowering blood pressure and cholesterol can slow down or prevent memory decline in people who carry a genetic risk for Alzheimer's disease. It aims to see if these treatments can help keep your brain healthy as you age.
This trial tests an experimental drug called HT-4253 to see if it can prevent Alzheimer's disease in people who are at higher genetic risk (carry the APOE4 gene) and have early signs of amyloid buildup in the brain. If you qualify, you would take the drug or a placebo and be monitored over time.
This study is a follow-up to the PENSA study. It checks whether a lifestyle program (about healthy habits) can help prevent memory decline over time in people who carry the APOE-ε4 gene.
Hear when a new Mild Cognitive Impairment (MCI) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.